【美国FDA前官员Cavazzoni将重返辉瑞,出任首席医疗官】辉瑞当地时间2月24日宣布,Patrizia Cavazzoni将出任公司首席医疗官,接替将离职寻求其他机会的Aida Habtezion。Cavazzoni最近的职务是美国食品药品监督管理局(FDA)药物评估与研究中心主任,于今年1月辞职。在此之前,Cavazzoni曾在辉瑞担任过多个高级职位,负责临床科学与开发业务。

金融界
25 Feb
辉瑞当地时间2月24日宣布,Patrizia Cavazzoni将出任公司首席医疗官,接替将离职寻求其他机会的Aida Habtezion。Cavazzoni最近的职务是美国食品药品监督管理局(FDA)药物评估与研究中心主任,于今年1月辞职。在此之前,Cavazzoni曾在辉瑞担任过多个高级职位,负责临床科学与开发业务。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10